How Toyota are helping people to walk again

By Georgia Allen
Share
Hospitals in Japan will soon be welcoming robotic machinery to help those with lower-limb paralysis. Toyotas Welwalk WW-1000 will begin roll-out in aut...

Hospitals in Japan will soon be welcoming robotic machinery to help those with lower-limb paralysis.

Toyota’s Welwalk WW-1000 will begin roll-out in autumn of this year and will be available to rent, but will cost £7,300 upfront as well as a monthly fee of £2,500.

The machinery attaches to the knee of the patient and enables those who have suffered from paralysis to walk again. Due to Japan’s aging population, this could be a crucial step as mobility problems rise and the machinery boasts that it can rehabilitate stroke victims 60% faster than normal physiotherapy.

The Welwalk is in line with a series of Toyota robots, who are being built to perform takes generally undertaken by care workers. Mundane tasks that are encountered with difficulty by those suffering could soon be performed by robotics counterparts as opposed to humans.

However, Toyota’s robot is currently only available in Japan and would have to be modified to cope with the physique of the western world, as the current model only supports 95kg of weight and those shorter than 6’3”.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma